LADENBURG THALMANN FINANCIAL SERVICES INC. - CLEVELAND BIOLABS INC ownership

CLEVELAND BIOLABS INC's ticker is CBLI and the CUSIP is 185860103. A total of 41 filers reported holding CLEVELAND BIOLABS INC in Q4 2013. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of CLEVELAND BIOLABS INC
ValueSharesWeighting
Q4 2014$260,000
-9.7%
744,200
+3.2%
0.01%
-25.0%
Q3 2014$288,000
-31.1%
721,2000.0%0.01%
-27.3%
Q2 2014$418,000
-17.6%
721,2000.0%0.01%
-26.7%
Q1 2014$507,000
-49.2%
721,200
-4.1%
0.02%
-51.6%
Q4 2013$999,000
-22.7%
752,0380.0%0.03%
-29.5%
Q3 2013$1,292,000
+10.2%
752,038
+0.8%
0.04%
+4.8%
Q2 2013$1,172,000746,2000.04%
Other shareholders
CLEVELAND BIOLABS INC shareholders Q4 2013
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 1,826,158$1,244,0000.07%
LADENBURG THALMANN FINANCIAL SERVICES INC. 721,200$507,0000.02%
Winfield Associates, Inc. 15,711$11,0000.01%
Van Cleef Asset Management,Inc 20,000$14,0000.01%
ACG Wealth 25,000$17,0000.01%
TAURUS ASSET MANAGEMENT, LLC 15,000$10,0000.00%
OPPENHEIMER & CO INC 25,500$17,0000.00%
AMERICAN INTERNATIONAL GROUP, INC. 500$341,0000.00%
BANK OF AMERICA CORP /DE/ 5,390$4,0000.00%
WELLS FARGO & COMPANY/MN 3,000$2,0000.00%
View complete list of CLEVELAND BIOLABS INC shareholders